Introduction to the Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases.

Siro Luvisetto
Author Information
  1. Siro Luvisetto: National Research Council of Italy-CNR, Institute of Biochemistry and Cell Biology (IBBC), Via Ercole Ramarini 32, Monterotondo Scalo, 00015 Roma, Italy. ORCID

Abstract

Studies on animals and humans have amply demonstrated the therapeutic efficacy of botulinum neurotoxins (BoNTs) in many pathologies [...].

References

  1. Toxins (Basel). 2022 Dec 30;15(1): [PMID: 36668850]
  2. Toxins (Basel). 2022 May 28;14(6): [PMID: 35737035]
  3. Toxins (Basel). 2023 Mar 28;15(4): [PMID: 37104185]
  4. Toxins (Basel). 2022 Oct 13;14(10): [PMID: 36287971]
  5. Toxins (Basel). 2022 Apr 11;14(4): [PMID: 35448880]
  6. Toxins (Basel). 2022 Nov 07;14(11): [PMID: 36356019]
  7. Toxins (Basel). 2022 Oct 12;14(10): [PMID: 36287970]
  8. Toxins (Basel). 2022 Apr 27;14(5): [PMID: 35622555]
  9. Toxins (Basel). 2022 Jan 17;14(1): [PMID: 35051042]
  10. Toxins (Basel). 2023 Apr 01;15(4): [PMID: 37104199]
  11. Toxins (Basel). 2022 May 15;14(5): [PMID: 35622589]
  12. Toxins (Basel). 2022 Feb 23;14(3): [PMID: 35324657]
  13. Toxins (Basel). 2022 Dec 28;15(1): [PMID: 36668840]
  14. Toxins (Basel). 2020 Sep 17;12(9): [PMID: 32957443]

MeSH Term

Animals
Humans
Botulinum Toxins
Neurotoxins

Chemicals

Botulinum Toxins
Neurotoxins

Word Cloud

Created with Highcharts 10.0.0StudiesanimalshumansamplydemonstratedtherapeuticefficacybotulinumneurotoxinsBoNTsmanypathologies[]IntroductionSpecialIssueBotulinumToxins:NewUsesTreatmentDiseases

Similar Articles

Cited By

No available data.